Jan 2021 /Anemia Effects and Management Recombinant human erythropoietin in pediatric oncology: a review. Feusner J, Hastings C Med Pediatr Oncol 2002;39(4):463-468. NATA Rating : Review by : Ford PANATA ReviewImportant to attempt review, but too much variability in studies to form meaningful conclusion. – Patricia Ford ANEMIA, CANCER, CHEMOTHERAPY PATIENTS, childhood cancer, CHILDREN, COMMUNITY ONCOLOGY, DOUBLE-BLIND, epoetin alfa, epoetin-alpha, MALIGNANCIES, PLACEBO-CONTROLLED TRIAL, QUALITY-OF-LIFE, treatment complications Share Post: The clinical value of erythropoietin in patients with cancer. The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study.